Literature DB >> 13233454

Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract.

D W WEISS, R J DUBOS.   

Abstract

It proved possible to increase the resistance of mice to tuberculous infection by vaccinating them with a suspension of avirulent tubercle bacilli killed by exposure to 2 per cent phenol. This increase in resistance was demonstrated by two different techniques: (a) observation of survival time of vaccinated animals following challenge infection with a large dose of virulent bacilli, and (b) determination of numbers of virulent bacilli in the spleens of animals 2 weeks after injection of a small infective dose. The minimum protective dose of vaccine corresponded to approximately one-tenth the acutely toxic dose. Addition of an adjuvant to the bacillary suspension markedly increased both the protective effectiveness of the vaccine and the duration of the immunity. It enhanced also the toxicity of the vaccine in approximately the same proportion. However, other lines of evidence suggested that toxicity and protective activity were independent one from the other and were the manifestations of different bacillary constituents. Extraction with absolute methanol released from the bacillary bodies a crude soluble fraction possessing low, if any, toxicity, yet capable of eliciting in mice a state of increased resistance to virulent infection. The protective activity of this methanol-soluble fraction was low; it accounted for only a small part of the total protective activity of the original material.

Entities:  

Keywords:  TUBERCULOSIS/immunology

Mesh:

Substances:

Year:  1955        PMID: 13233454      PMCID: PMC2136471          DOI: 10.1084/jem.101.3.313

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  [New experimental proof of the immunizing action of methyl antigen].

Authors:  L NEGRE; J BRETEY
Journal:  Rev Tuberc       Date:  1953

2.  Killed anti-tuberculosis vaccine and hyaluronidase (diffusing vaccine).

Authors:  G SALVIOLI
Journal:  Arch Dis Child       Date:  1953-02       Impact factor: 3.791

3.  Vaccination against paratuberculosis (Johne's disease).

Authors:  B SIGURDSSON
Journal:  J Immunol       Date:  1952-05       Impact factor: 5.422

4.  Cold stain for acid-fast bacteria.

Authors:  E AUBERT
Journal:  Can J Public Health       Date:  1950-01

5.  A fraction of tubercle bacilli possessing primary toxicity.

Authors:  J K SPITZNAGEL; R J DUBOS
Journal:  J Exp Med       Date:  1955-03-01       Impact factor: 14.307

6.  Antituberculous immunity in mice vaccinated with killed tubercle bacilli.

Authors:  R J DUBOS; W B SCHAEFER; C H PIERCE
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

7.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

  7 in total
  13 in total

Review 1.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 2.  Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

Authors:  A M Dannenberg
Journal:  Bacteriol Rev       Date:  1968-06

3.  Immunostimulation with bacterial phospholipid extracts.

Authors:  R M Fauve; B Hevin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

4.  Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex.

Authors:  A Laqueyrerie; P Militzer; F Romain; K Eiglmeier; S Cole; G Marchal
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria.

Authors:  F Romain; A Laqueyrerie; P Militzer; P Pescher; P Chavarot; M Lagranderie; G Auregan; M Gheorghiu; G Marchal
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria.

Authors:  F Romain; J Augier; P Pescher; G Marchal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Studies on tubercle bacillus-monocyte relationship. III. Conditions affecting the action of serum and cells; modification of bacilli in an immune system.

Authors:  J FONG; D CHIN; H J AKIYAMA; S S ELBERG
Journal:  J Exp Med       Date:  1959-06-01       Impact factor: 14.307

8.  STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION.

Authors:  D W WEISS; R S BONHAG; J A PARKS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

9.  Antituberculous immunity induced by methanol extracts of tubercle bacilli; its enhancement by adjuvants.

Authors:  D W WEISS; R J DUBOS
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

10.  A fraction of tubercle bacilli possessing primary toxicity.

Authors:  J K SPITZNAGEL; R J DUBOS
Journal:  J Exp Med       Date:  1955-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.